Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
06/2003
06/26/2003WO2003051846A2 Substituted phenyl derivatives
06/26/2003WO2003051845A1 Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051833A2 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
06/26/2003WO2003051820A1 Method for producing 2-halogenacyl-3-amino-acrylic acid derivatives
06/26/2003WO2003051358A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/26/2003WO2003051119A1 New herbicidal compounds and method
06/26/2003WO2003024400A3 Process for the preparation of 1,5-diarylpyrazoles
06/26/2003US20030120085 Novel benzamidoxime derivatives, intermediates and processes for their preparation, and their use as fungicides
06/26/2003US20030119886 Nonsteroidal antiinflammatory agents, e.g., N-hydroxy-1-(4-sulfonyl or aminosulfonyl)phenyl)-(ring- substituted hetero-cyclyl)alkanamide or -urea; dual enzyme inhibitors with minimal side effects; asthma; antiallergens; antipyretics
06/26/2003US20030119873 Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
06/26/2003US20030119715 Prevent retinoid binding; antiaging agents; activation cell differentiation
06/26/2003US20030115684 Couplers for oxidative hair dyes
06/26/2003CA2470616A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/26/2003CA2470276A1 Substituted phenyl derivatives
06/26/2003CA2470214A1 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
06/26/2003CA2469305A1 Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP1320527A1 Method for producing 1 substituted 5-chloro-4 methyl pyrazoles
06/25/2003EP1320520A1 Sulfonylguanidine
06/25/2003EP1025086B1 Benzamidine derivatives as factor xa inhibitors
06/25/2003EP0906094B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/25/2003EP0847388B1 Heterocyclically substituted biphenylamide derivatives, their preparation and their use as fungicides
06/25/2003CN1112359C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF)
06/24/2003US6583282 Formation of a urea by reacting an aromatic carbamate with a aromatic amine
06/24/2003US6583165 Anticarcinogenic, -inflammatory and -proliferative agents; viricides; bactericides; vascular restenosis, autoimmune diseases; psoriasis; anticolesterol and -lipemic agents
06/24/2003US6583090 Hetaryl-substituted benzyl phenyl ethers, method for the production thereof, and their use for combating harmful fungi and animal pests
06/24/2003CA2288910C Pyrazolopyrimidinones for sexual dysfunction
06/19/2003WO2003050261A2 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
06/19/2003WO2003050091A1 Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003US20030114432 Antiinflammatory agents; rheumatic diseases; anticancer agents
06/19/2003US20030114423 Arylamines as inhibitors of chemokine binding to US28
06/19/2003CA2471743A1 Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/18/2003EP1319657A1 N-(4-pyrazolyl)amide derivatives, chemicals for agricultural and horticultural use, and usage of the same
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1318974A2 Resorcinol derivatives
06/18/2003EP1318836A2 Treatment of hyperproliferative diseases
06/18/2003EP1318802A2 Substituted hydrazine derivatives
06/18/2003EP1168920B1 (s)-enantiomer enriched fipronil composition
06/18/2003CN1425002A Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders
06/17/2003US6579988 Processes for the preparation of 1,5-diarylpyrazoles
06/12/2003WO2003048155A1 Thrombin inhibitors
06/12/2003WO2003048123A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/12/2003WO2003048121A1 Therapeutic benzamide derivatives
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003US20030109717 Chemical intermediates for herbicides; cyclization of a diacylhydrazine
06/12/2003US20030109715 3,4-Dihydro-1H-naphthalene derivatives as a highly selective cyclooxygenase-2 inhibitor
06/12/2003US20030109709 Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles
06/12/2003US20030109705 Novel cyanoenamines useful as ligands for modulating gene expression in plants or animals
06/12/2003US20030109703 Antiinflammatory agents; autoimmune disease
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109550 Substituted indazole compounds for the treatment of inflammation
06/12/2003US20030109459 Activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
06/12/2003CA2467435A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/11/2003EP1318145A1 Processes for the preparation of pyrazole compounds
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1317433A2 Inhibitors of glycogen synthase kinase 3
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/11/2003EP1001937B1 Method for producing 2-(3-pyrazolyl-oxymethylene) nitrobenzenes
06/11/2003CN1423631A Phenacylamine derivatives, production thereof and pest controllers containing the derivatives
06/11/2003CN1422849A 吲唑衍生物 Indazole derivative
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/05/2003WO2003045912A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
06/05/2003WO2003045379A1 Hydrazonopyrazole derivatives and their use as therapeutics
06/05/2003WO2002048137A3 Substituted heterocyclic phthalic acid diamide arthropodicides
06/05/2003US20030105336 Pyrazole derivatives, their preparation and their use in pharmaceuticals
06/05/2003US20030105292 Continously induced g-protein coupled receptors; membrane binding assays
06/05/2003US20030105144 Celecoxib dissolving in polyethylene glycol; antiinflammatory agents, osteoporosis, respiratory system disorders, antitumor agents, analgesics
06/05/2003US20030105143 Bactericides, antiseptics, cosmetics, cleaning compounds, enhaned oil recovery, papermaking
06/05/2003US20030105141 Mixture containing fatty acid and aromatic amine; administering by mouth; cyclooxygenase enzyme inhibitor
06/05/2003US20030105132 N-phenpropylcuclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
06/05/2003US20030105105 As anticoagulant agents for therapy and prophylaxis of thromboembolic disorders
06/05/2003US20030104324 Yellow coupler and silver halide color photographic lightsensitive material containing the same
06/04/2003EP1315703A1 Aryl substituted tetrahydroindazoles and their use as ligands for the gaba-a receptor
06/04/2003EP1315500A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
06/04/2003EP1315491A2 Method for treating allergies using substituted pyrazoles
06/04/2003EP1062217B1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
06/04/2003EP0862545B1 Pesticide compounds, compositions and process for the preparation thereof
06/04/2003CN1422258A Benzoylpyrazols and their use as herbicides
06/04/2003CN1422257A Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker
06/04/2003CN1421439A Process for producing insecticide intermediate
06/04/2003CN1421438A Prepn process of thianidazole
06/03/2003US6573291 Method and use
06/03/2003US6573287 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
06/03/2003US6573270 Endothelin receptor antagonists
06/03/2003US6573252 Therapy and prevention of bony disorders; improved gastrointestinal tolerability
05/2003
05/29/2003US20030100751 Coupling condensation synthesis of heterocycles
05/29/2003US20030100594 Carbonic anhydrase inhibitor
05/29/2003US20030100554 Pyrazole derivatives
05/28/2003EP1314712A1 Nf-kappa-b inhibitor containing substituted benzoic acid derivative as active ingredient
05/28/2003EP1313711A2 Indazole derivatives as jnk inhibitors
05/28/2003EP1313710A1 Pyrazole derivatives and their use as protein kinase inhibitors
05/28/2003EP1313709A1 Pyrazolyl biphenyl carboxamides
05/28/2003EP1065205B1 Heteroaromatic derivatives
05/28/2003CN1109673C Improved methods of preparing 4-cyano-4-(substd. indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors
1 ... 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 ... 256